TherapeuticsMD
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $724 | $893 | $784 | $952 |
Gross Profit | 399 | 893 | 784 | 952 |
EBITDA | -398 | -3,242 | 149 | -223 |
EBIT | -723 | -4,148 | 53 | -319 |
Net Income | 95 | -619 | 152 | 551 |
Net Change In Cash | 724 | 893 | 784 | 952 |
Free Cash Flow | 936 | 368 | 1,046 | 324 |
Cash | 8,419 | 7,483 | 7,115 | 6,069 |
Basic Shares | 11,640 | 11,569 | 11,574 | 11,574 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $3,022 | $1,761 | $1,302 | $69,963 |
Gross Profit | 1,829 | 1,761 | 1,302 | 68,566 |
EBITDA | -3,021 | -2,983 | -8,084 | 11,863 |
EBIT | -4,214 | -3,492 | -8,523 | 10,663 |
Net Income | -569 | -2,181 | -10,278 | 111,997 |
Net Change In Cash | 3,022 | 1,761 | 1,302 | 69,963 |
Free Cash Flow | 2,424 | 732 | -48,141 | -4,433 |
Cash | 7,483 | 5,059 | 4,327 | 38,067 |
Basic Shares | 11,569 | 11,532 | 10,441 | 9,028 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0 |
2025-09-30 | $0 |
2025-06-30 | $0.05 |